Stock Analysis

Here's Why Ainos (NASDAQ:AIMD) Can Afford Some Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. We can see that Ainos, Inc. (NASDAQ:AIMD) does use debt in its business. But the more important question is: how much risk is that debt creating?

Advertisement

Why Does Debt Bring Risk?

Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. Part and parcel of capitalism is the process of 'creative destruction' where failed businesses are mercilessly liquidated by their bankers. However, a more common (but still painful) scenario is that it has to raise new equity capital at a low price, thus permanently diluting shareholders. By replacing dilution, though, debt can be an extremely good tool for businesses that need capital to invest in growth at high rates of return. The first step when considering a company's debt levels is to consider its cash and debt together.

Check out our latest analysis for Ainos

What Is Ainos's Debt?

You can click the graphic below for the historical numbers, but it shows that Ainos had US$3.56m of debt in March 2023, down from US$31.3m, one year before. However, because it has a cash reserve of US$1.15m, its net debt is less, at about US$2.41m.

debt-equity-history-analysis
NasdaqCM:AIMD Debt to Equity History May 15th 2023

How Strong Is Ainos' Balance Sheet?

The latest balance sheet data shows that Ainos had liabilities of US$1.87m due within a year, and liabilities of US$2.50m falling due after that. On the other hand, it had cash of US$1.15m and US$1.61m worth of receivables due within a year. So its liabilities outweigh the sum of its cash and (near-term) receivables by US$1.61m.

Given Ainos has a market capitalization of US$14.4m, it's hard to believe these liabilities pose much threat. But there are sufficient liabilities that we would certainly recommend shareholders continue to monitor the balance sheet, going forward. There's no doubt that we learn most about debt from the balance sheet. But you can't view debt in total isolation; since Ainos will need earnings to service that debt. So when considering debt, it's definitely worth looking at the earnings trend. Click here for an interactive snapshot.

In the last year Ainos wasn't profitable at an EBIT level, but managed to grow its revenue by 412%, to US$3.5m. That's virtually the hole-in-one of revenue growth!

Caveat Emptor

Despite the top line growth, Ainos still had an earnings before interest and tax (EBIT) loss over the last year. Its EBIT loss was a whopping US$14m. Considering that alongside the liabilities mentioned above does not give us much confidence that company should be using so much debt. So we think its balance sheet is a little strained, though not beyond repair. However, it doesn't help that it burned through US$3.6m of cash over the last year. So suffice it to say we consider the stock very risky. The balance sheet is clearly the area to focus on when you are analysing debt. But ultimately, every company can contain risks that exist outside of the balance sheet. For example Ainos has 6 warning signs (and 4 which make us uncomfortable) we think you should know about.

At the end of the day, it's often better to focus on companies that are free from net debt. You can access our special list of such companies (all with a track record of profit growth). It's free.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqCM:AIMD

Ainos

A dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics.

Medium-low risk and slightly overvalued.

Advertisement

Weekly Picks

RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8696.7% undervalued
75 users have followed this narrative
7 users have commented on this narrative
21 users have liked this narrative
RO
Robbo
FID logo
Robbo on Fiducian Group ·

Fiducian: Compliance Clouds or Value Opportunity?

Fair Value:AU$121.2% undervalued
13 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
WO
WVVI logo
woodworthfund on Willamette Valley Vineyards ·

Willamette Valley Vineyards (WVVI): Not-So-Great Value

Fair Value:US$245.0% overvalued
11 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

NO
S5L logo
Norms70 on Standard Lithium ·

SLI is share to watch next 5 years

Fair Value:€4.59.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
davidlsander
BEAM logo
davidlsander on Beam Therapeutics ·

The "Molecular Pencil": Why Beam's Technology is Built to Win

Fair Value:US$15081.9% undervalued
61 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative
RE
PRME logo
RedhawkCC on Prime Medicine ·

PRME remains a long shot but publication in the New England Journal of Medicine helps.

Fair Value:US$0.0469.1k% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.5% undervalued
118 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3925.9% undervalued
962 users have followed this narrative
6 users have commented on this narrative
25 users have liked this narrative
RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8696.7% undervalued
75 users have followed this narrative
7 users have commented on this narrative
21 users have liked this narrative